Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,005 public trials 1,217 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma

NCT00311584

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States

Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Southern California Permanente Medical Group Downey, California, United States

View all 128 locations

View Trial Details

Completed

Evaluation of a Simulation Training Tool to Identify Lesions Requiring Further Screening for Melanoma

NCT01191294

Conditions: Mastery Learning Model to Simulation Training for Visual Screening for Melanoma and Skin Biopsy, Melanoma, Neoplasms, +11 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors

NCT00618813

Conditions: Ewing Sarcoma of Bone, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Neoplasms, +8 more
Locations: Children's Oncology Group Monrovia, California, United States

View Trial Details

Completed

Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma

NCT00960492

Conditions: Astrocytoma, Giant Cell Glioblastoma, Glioblastoma, +9 more
Locations: UCLA Los Angeles, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Henry Ford Health System Detroit, Michigan, United States

Beth Israel Medical Center New York, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

NCT00003107

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +116 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

NCT00027534

Conditions: Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +70 more
Locations: Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

NCT00445731

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +96 more
Locations: Not specified

View Trial Details

Completed

Phase II Trial of Ontak With Metastatic Melanoma

NCT00299689

Conditions: Malignant Melanoma, Melanoma, Neoplasm Metastasis, +14 more
Locations: James Graham Brown Cancer Center, Univ. of Louisville Louisville, Kentucky, United States

View Trial Details

Completed

Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection

NCT01006044

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Clínica Universidad de Navarra Pamplona, Spain

View Trial Details

Completed

Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma

NCT00516295

Conditions: Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Neoplasms, +10 more
Locations: Children's Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions